Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2013 by Brigham and Women's Hospital
Sponsor:
Information provided by (Responsible Party):
Rodney H. Falk, MD, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT01855360
First received: March 12, 2013
Last updated: November 19, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)